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(B) Abstract 
 
Misfolding, polymerization and defective secretion of functional α1-antitrypsin underlies the 
predisposition to severe liver and lung disease in α1-antitrypsin deficiency.  We have identified a 
novel (Ala336Pro, Baghdad) deficiency variant and characterized it relative to the wild-type (M) 
and Glu342Lys (Z) alleles.  The index case is a homozygous individual of consanguineous parentage, 
with levels of circulating α1-antitrypsin in the moderate deficiency range, but a biochemical 
phenotype that could not be classified by standard methods.  The majority of the protein was 
present as functionally inactive polymer, and the remaining monomer was 37% active relative to 
the wild-type protein.  These factors combined indicate a 85-95% functional deficiency, similar to 
that seen with ZZ homozygotes.  Biochemical, biophysical and computational studies further 
defined the molecular basis of this deficiency.  These demonstrated that native Ala336Pro α1-
antitrypsin could populate the polymerogenic intermediate – and therefore polymerize – more 
readily than either wild-type α1-antitrypsin or the Z variant.  In contrast, folding was far less 
impaired in Ala336Pro α1-antitrypsin than in the Z variant. The data are consistent with a disparate 
contribution by the ‘breach’ region and ‘shutter’ region of strand 5A to folding and to 
polymerization mechanisms. Moreover, the findings demonstrate that in these variants, folding 
efficiency does not correlate directly with the tendency to polymerize in vitro or in vivo.  They 
therefore differentiate generalized misfolding from polymerization tendencies in missense variants 
of α1-antitrypsin. Clinically they further support the need to quantify loss-of-function in α1-
antitrypsin deficiency to individualize patient care. 
 
(C) Keywords 
 
α1-antitrypsin deficiency, polymerization, intermediate, mutation, protease inhibition, unfolding, 
refolding, serpinopathies 
 
Abbreviations 
AF488, Alexa Fluor 488; AF594, Alexa Fluor 594; CD, circular dichroism; COSM, centre of spectral 
mass; IEF, isoelectric focusing; kass, second-order association rate constant; PAGE, polyacrylamide 
gel electrophoresis; PBS, phosphate-buffered saline; SI, stoichiometry of inhibition. 
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(D) Text 
 
Introduction 
 
α1-Antitrypsin is produced in the liver, circulates as the most abundant antiprotease, and critically 
regulates activity of neutrophil elastase and proteinase-3 in the lung. Its mechanism of action 
involves a transition from a metastable native state with a 5-stranded central β-sheet to a 
thermodynamically favored 6-stranded central β-sheet conformation.  This metastability is 
subverted by pathogenic mutations in α1-antitrypsin deficiency, one of the most common 
hereditary disorders. Over 120 mutations in the SERPINA1 gene encoding α1-antitrypsin have been 
identified, with approximately 80 implicated in disease pathogenesis, indicative of a highly 
polymorphic gene (1).  Current screening involves quantification of circulating levels, with M (wild-
type; ATM) homozygotes (PiMM) ranging between 1.0–2.8 g/L of α1-antitrypsin (2); clinically-
relevant deficiency is considered when levels are ≤0.5 g/L. Isoelectric focusing (IEF) of the plasma 
protein identifies variants by their migration patterns (3). Around 95% of clinically-significant 
deficiency is caused by the Z (Glu342Lys; ATZ) pathogenic variant. Approximately 1 in 1600 
individuals in populations of North European descent are homozygous for this allele (PiZZ), and in 
these individuals plasma levels are ≤0.2 g/L (4, 5). Misfolding of the Z α1-antitrypsin polypeptide 
chain results in degradation (6), but is also associated with accumulation of α1-antitrypsin 
molecules that have undergone aberrant stabilization through ordered self-association 
(polymerization). Polymers have a ‘beads-on-a-string’ appearance when viewed by electron 
microscopy (7) and are sequestered within inclusions in the endoplasmic reticulum (ER) of 
hepatocytes (8). Polymerization is associated with toxic gain-of-function and so predisposes to 
neonatal hepatitis, cirrhosis and hepatocellular carcinoma (9).  The lack of circulating inhibitor 
permits excessive pulmonary inflammation, uncontrolled proteolytic degradation of lung 
parenchyma and hence severe panlobular emphysema, particularly in the context of smoking (10). 
These loss-of-function effects may be further aggravated by functional inactivation of α1-
antitrypsin by oxidative stress and polymerization of circulating protein (8, 11). 
 
α1-Antitrypsin adopts the conserved fold that is a hallmark of the serpin superfamily (12), 
comprising three β-sheets (A-C), nine α-helices (A-I) and a ‘reactive centre loop’ (RCL) bait 
sequence that acts as a pseudo-substrate for the target protease (Fig. 1A, left).  Structural lability of 
the central β-sheet A is required for inhibitor function, but is also key to formation of ordered 
polymers. Here we describe a novel mutation affecting a central residue in β-sheet A, Ala336Pro, in 
a homozygous individual exhibiting a moderate deficiency of circulating α1-antitrypsin. The novel 
variant (α1-antitrypsin Baghdad; ATA336P) has been investigated using immunological and 
biophysical approaches. The results show the individual to have a severe functional deficiency far 
beyond the reduction in plasma levels and that the homozygous state therefore confers comparable 
emphysema risk to that of PiZZ individuals. Additionally, the mutant provides mechanistic insight 
into the role of strand 5 of β-sheet A in the formation of the intermediate and subsequent steps in 
α1-antitrypsin polymerization and the relationship between misfolding and polymerization. 
 
 
Materials and Methods 
 
Purification of α1-antitrypsin and preparation of conformers 
 
α1-Antitrypsin was purified from human plasma using Alpha Select resin followed by Q Sepharose 
chromatography (GE Healthcare), and stored in phosphate-buffered saline (PBS), 5% v/v glycerol 
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and 0.17% v/v β–mercaptoethanol at -80°C.  Wild-type (ATM) protein purified in this way was 
indistinguishable from that obtained using previously published methods (13) when assessed by 
inhibitory activity, intrinsic tryptophan fluorescence, circular dichroism (CD) spectra or liquid 
chromatography mass spectroscopy (14). 
  
 
Gel electrophoresis and western blot analysis 
 
Plasma samples, diluted 1:100, were resolved by non-denaturing PAGE (polyacrylamide gel 
electrophoresis; Life Technologies) and transferred onto a PVDF membrane.  Primary incubation 
was with the 2C1 antibody that specifically recognizes α1-antitrypsin polymers (9) or a non-
conformationally-selective rabbit polyclonal antibody against α1-antitrypsin.  The membrane was 
then washed and incubated with IR680RD anti-mouse or IR800CW anti-rabbit secondary 
antibodies with visualization using an Odyssey imaging system (LiCOR).  All densitometry was 
performed using ImageJ (15).  8% w/v urea Tris-Glycine gels were produced using an SDS-free 
Laemmli system (16) with the addition of urea to 6M.   
 
 
Assessment of proteinase inhibition 
 
The stoichiometry of inhibition (SI) and association rate constant of α1-antitrypsin (kass) were 
assessed at 25°C using bovine α-chymotrypsin as described previously (17).  The ability to form an 
enzyme-inhibitor complex was assessed by incubating differing concentrations of protease with α1-
antitrypsin and resolution (without heating) by SDS-PAGE. 
 
 
Spectral studies 
 
Far-UV CD spectra were collected using a Jasco J-810 spectropolarimeter as described previously 
(17).  Intrinsic fluorescence spectra (emission 300-400 nm) were collected using a Perkin Elmer 
LS50B spectrofluorimeter (excitation 280 nm, scan 500nm/s, 10 accumulations, 5nm slits).   The 
centre of spectral mass (COSM) was calculated as a weighted average, with the intensity at each 
wavelength weighted by the wavenumber 1/λ. Bis-ANS (4,4'-Dianilino-1,1'-Binaphthyl-5,5'-
Disulfonic Acid) spectra (excitation 370nm, emission 400-600nm) were collected following a 2 
minute incubation of 10 μM dye with 2 μM α1-antitrypsin in PBS. 
 
 
Molecular modeling 
 
The mutation was modeled against the wild-type structure [1QLP (18)] using VMD (19) and NAMD 
(20) as described in the Supplementary text. 
 
 
Thermal denaturation 
 
The transition to the polymerization intermediate was monitored using a SYPRO Orange-based 
thermal denaturation assay as described previously (17), using various rates of temperature 
increase. 
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Polymerization kinetics monitored by FRET 
 
The Cys232 residue of α1-antitrypsin was labeled with Alexa Fluor 488 (AF488) maleimide and 
Alexa Fluor 594 (AF594) maleimide (Life Technologies). Polymerization was monitored as the 
increase in acceptor (AF594) fluorescence at 615nm with excitation of donor (AF488) at 470 nm 
using a Mastercycler realplex4 instrument (Eppendorf), as described (17, 21, 22). 
 
 
Equilibrium unfolding/dilution refolding 
 
Unfolding curves were obtained by incubating α1-antitrypsin with guanidinium hydrochloride for 3 
hours at room temperature, before recording intrinsic fluorescence spectra as described above.  
Derived COSM values were fitted to a three state unfolding model (23).  Refolding involved 
denaturing a 10mg/ml stock of α1-antitrypsin overnight at 4°C in 6M guanidinium hydrochloride, 
followed by rapid dilution into PBS containing 5% v/v glycerol to 0.05mg/ml, and resolution on a 
3–12% w/v non-denaturing gel.  
 
 
Results 
 
Clinical case 
 
A 41-year-old female, never-smoker of Iraqi origin was referred to the London Alpha-1 Antitrypsin 
Deficiency Service after her serum α1-antitrypsin levels were measured at 0.4 g/L (normal range 
1.0–2.8 g/L).  She had been investigated for an ulnar neuropathy that resolved spontaneously. 
Family history revealed that her parents were first cousins. She reported no symptoms associated 
with α1-antitrypsin deficiency. She was married to a third cousin with whom she had two children 
who are both alive and well. IEF phenotyping of circulating α1-antitrypsin repeatedly produced an 
‘unclear result’ (Supp. Fig. E1A).  Standard liver function tests (including bilirubin, alkaline 
phosphatase, alanine transaminase, aspartate aminotransferase and γ-glutamyl transferase) were 
normal, albumin levels were marginally elevated, and there were no abnormalities on hepatic 
imaging by ultrasound or fibroscan.  Lung function tests including spirometry and gas transfer 
indices were also normal. There was no abnormality of circulating anti-neutrophil cytoplasmic 
antibody (ANCA). In view of the circulating deficiency and unclear phenotyping, SERPINA1 
genotyping was undertaken and identified homozygosity for a non-synonymous G1078C mutation, 
resulting in an Ala336Pro substitution that has not previously been described. This novel variant 
was named α1-antitrypsin Baghdad (here also referred to as ATA336P) after the birthplace of the 
index case. 
 
 
Ala336Pro mutation occurs in a hot-spot for polymerogenic mutants and results in substantial 
polymerization in vivo 
 
Ala336 is located centrally to strand 5 of β-sheet A (strand 5A, s5A) in α1-antitrypsin in a region 
known as the ‘shutter’ (24) with a side-chain directed into the interior of the protein (Fig. 1A, left 
panels).  Residues within this region are known to regulate the opening of β-sheet A for 
incorporation of the reactive centre loop as a neighboring strand (s4A) (25).  Therefore, mutations 
in these residues can affect functional activity and the propensity to polymerize (24).  In particular, 
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in the native conformation, Ala336 packs against Phe51, whose interactions contribute to the sheet-
opening mechanism (26).  Mutations at adjacent sites (Supp. Fig. E1B) result in highly 
polymerogenic variants of α1-antitrypsin: Siiyama, Ser53Pro (27); Mmalton , Phe51del (28); and King’s, 
His 336Asp (9).  Accordingly, western blot analysis of patient plasma, separated by non-denaturing 
PAGE, indicated that the Baghdad variant was predominantly circulating as polymers that were 
recognized by the 2C1 monoclonal antibody.  This indicates the Ala336Pro mutation results in 
polymers that share an epitope with pathological polymers of the Z variant that are observed in 
vivo (Fig. 1B, right).   
 
 
Ala336Pro mutation reduces the inhibitory activity of α1-antitrypsin 
 
Monomeric ATA336P α1-antitrypsin was purified from plasma, and found to require a 2.7-fold greater 
stoichiometric excess (SI) over a model protease (α-chymotrypsin) than ATM to achieve full 
inhibition (Table 1 and Fig. 1C).  This reduction in activity is greater than that observed for ATZ, and 
will increase the unproductive turnover of inhibitor, resulting in the release of RCL-cleaved serpin 
and active protease.  This was confirmed by SDS-PAGE analysis of the interaction with α-
chymotrypsin at twice the stoichiometry of inhibitor-to-enzyme.  Consistent with the kinetic 
experiments, the amount of α1-antitrypsin that formed complex with α-chymotrypsin relative to the 
cleaved, non-complexed protein, was lower for ATA336P than for ATZ (Supp. Fig. E1C).  In addition to 
this decrease in the efficiency of protease inhibition due to increased unproductive turnover, the 
Ala336Pro mutation also reduced the rate of the interaction: the association rate constant (kass) was 
13% that of ATM (Table 1), lower than observed for Z α1-antitrypsin (53% of ATM). This suggests a 
sub-optimal RCL conformation for the encounter between α1-antitrypsin and target protease. These 
deficits together with the reduction in circulating levels equates to a predicted in situ inhibitory 
rate that is two orders of magnitude slower for an Ala336Pro α1-antitrypsin homozygote than for 
an M α1-antitrypsin homozygote.  This is comparable with the functional deficiency in Z α1-
antitrypsin homozygotes (Table 1, right column).  In practice these values will significantly 
underestimate the loss-of-function for the deficiency variants as they do not account for the further 
reductions due to the proportion of α1-antitrypsin circulating as functionally inactive polymers. 
 
 
The proline substitution destabilizes β-sheet A by disrupting strand 5A-6A hydrogen bonds  
 
The alanine-to-proline change represents a substitution that is predicted to alter local structure.  
While a bulkier side-chain may have some effect, it is an inherent restriction of backbone 
conformation that is expected to exert the greatest influence; proline residues are known act as 
‘strand-breakers’ by disrupting the periodicity of the backbone angles inherent in these structural 
elements.  To investigate the possibility of significant loss of secondary structure, circular 
dichroism spectra were recorded in the far-UV range.  The substantially similar profile indicated a 
lack of change to the overall protein secondary structure, and thus a globally intact protein (Fig. 
2A).  However, differences were observed in the intrinsic tryptophan fluorescence spectrum of 
ATA336P (Fig. 2B).  In α1-antitrypsin, the two tryptophan residues (Trp194 and Trp238) dominate 
the fluorescence profile, reporting changes in the breach region at the top of β-sheet A between s5A 
and s3A, and β-sheet B, respectively (29).  The intensity of the ATA336P spectrum was found to be 
intermediate between that of ATM and ATZ variants, with a ‘red-shift’ of the peak maximum in 
common with ATZ.  By analogy with ATZ, this is highly likely to reflect differences in side-chain 
arrangements and an altered dynamic behavior that increases average solvent exposure in the 
vicinity of the breach of β-sheet A (30).  This region is the site of the ‘proximal’ (N-terminal) hinge 
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of the RCL, and the compromised kass value noted for ATA336P suggests the altered dynamics 
increase the proportion of molecules at a given time point with incompatible presentation of the 
protease recognition site.  The environment-sensitive dye bis-ANS reports the presence of a 
hydrophobic binding site which coincides with the transition to a polymerization intermediate 
(31).  This dye displays enhanced fluorescence in the presence of  the ATZ mutant (30), and yielded 
a comparable increase in ATA336P fluorescence over that of ATM (Fig. 2C), consistent with an 
increased population of the intermediate state. 
 
The structural consequences of the Ala336Pro mutation on the conformation of the protein were 
investigated in silico using the NAMD (20) and VMD (19) packages.  In the resulting model, the 
constraints imposed by the pyrrolidine ring of Pro336 do not disrupt strand 5A, consistent with a 
subset of backbone angles favored by proline residues that coincide with the β-sheet region of the 
Ramachandran plot.  Indeed, it has been noted that proline residues can be accommodated in 
regions of a β-sheet that tolerate the disruption of the periodic main-chain hydrogen bonding, such 
as β-sheet edge strands (32). Consistent with this ‘edge-strand-effect’, the model predicts loss of 
two hydrogen bonds between strands 5A and 6A that partly disrupts the neighboring s6A backbone 
conformation (Fig. 1A, right panels and Supp. Figs. E1D and E1E). The s6A-helix I-s5A sequence 
forms a contiguous structural unit that abuts the site of RCL incorporation during conformational 
change, parts of which show enhanced exchange properties with the solvent in ATZ (33).  The 
effects on inhibitory activity suggest that the resulting reduction in β-sheet A stability is associated 
with changes in the conformational behavior of the RCL. 
 
 
The native state is less stable in the mutant than wild-type 
 
The centre of spectral mass (COSM), calculated from intrinsic fluorescence of α1-antitrypsin under 
pseudo-equilibrium denaturing conditions, reflects changes in solvent exposure predominantly of 
Trp194 at low concentrations with an increasing contribution from Trp238 at higher 
concentrations (30).  It thus largely represents a probe of breach conformational stability, which 
follows a three-state unfolding pathway (34) that can be summarized as follows: 
 
Predominantly closed (M-like) ↔ Open (Z-like) ↔ Unfolded 
 
Support for the scheme proposed here comes from similar red-shifted intrinsic spectral (30) and 
bis-ANS binding (34) properties for the M and Z α1-antitrypsin variants in unfolding intermediate-
inducing concentrations of denaturant (30). 
 
Intrinsic protein fluorescence spectra were collected during pseudo-equilibrium unfolding of the 
three variants, and COSM values calculated.  The resulting data were well-described by a three-
state equation (Fig. 3A).  The shapes of the plots show that an exposure of Trp194 characteristic of 
the intermediate state is already adopted by ATZ.  Native ATA336P was found to be juxtaposed 
between ATM and ATZ, indicating the dynamic equilibrium shifted towards increased solvent 
exposure in the vicinity of the breach.  The unfolding intermediates of ATM and ATA336P adopted a 
native Z-like COSM value, with the midpoints of the transitions indicating that ATA336P adopts this 
state at a lower denaturant concentration than ATM (Table 2).   In contrast, the transition to the 
unfolded state was slightly earlier in ATA336P than the other two variants.  Together these data 
support a continued role for central strand 5A interactions in the denaturant-induced ATM 
intermediate as it adopts Z-like dynamic behavior in the breach. 
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The loop-inserted conformation is less stable in the mutant than wild-type 
 
Disruption of the integrity of β-sheet A by the introduction of a mid-strand proline might be 
expected to destabilize the loop-inserted conformation of α1-antitrypsin.  This hyperstable, 
thermodynamically-preferred state is achieved following cleavage of the RCL by a protease or 
partial misfolding to the latent form; additionally, the prevailing models of polymerization 
predicate a loop-inserted state for the repeating subunit.  Protein, cleaved with Staphylococcus 
aureus protease V8 (35), was incubated in increasing concentrations of guanidinium hydrochloride 
for 2 hours, and resolved by PAGE using a 6M urea gel.  This system preserved intact cleaved α1-
antitrypsin but prevented refolding of denatured protein on the gel.  The resulting profile showed a 
transition for ATA336P from folded to unfolded at 5.5 M guanidinium hydrochloride, a concentration 
approximately 0.5 M lower than that required to unfold cleaved ATM and ATZ (Fig. 3B).  Thus, a 
destabilized β-sheet A manifests a decreased thermodynamic stability of the 6-stranded form. 
 
 
The folding efficiency of Z α1-antitrypsin is lower than that of the Ala336Pro variant 
 
The α1-antitrypsin variants were subjected to snap-refolding by a 200-fold dilution from a 10 
mg/ml stock, and visualized by non-denaturing PAGE (Fig. 3C, top panel).  The gels showed 
development of three conformations: monomer, a slower-migrating band reflecting the 
intermediate, and an oligomeric species likely to be dimer.    Densitometry revealed the recovery of 
material to be incomplete on refolding, with 87.5%, 72.8% and 44.7% activity regained for ATM, 
ATA336P and ATZ, respectively (Fig. 3C, lower panel). ATA336P was therefore able to fold almost as 
well as ATM, in contrast to ATZ. Upon refolding, ATA336P populated the intermediate state more than 
ATM but less than ATZ, whilst it formed the oligomeric state to a greater extent than either. 
 
These observations, combined with the character of the intermediate in the presence of denaturant, 
indicate that Glu342 is foremost a ‘gatekeeper’ amino acid that is of particular importance in the 
folding pathway. However it is less important in preventing formation of ordered polymers 
associated with refolding. Conversely, the residues of the shutter are required for native stability 
and function, and the Ala336Pro mutation perturbs this to allow self-association after substantial 
refolding.    
 
 
Ala336Pro allows the polymerization intermediate to form more readily than the Z mutation 
 
Polymerization of α1-antitrypsin can be induced by heat, yielding polymers that share an epitope 
with ex vivo material (9).  Thermal challenge represents a tool for investigating the effect of a 
mutation on the polymerization pathway, which observes a progression from monomer native 
state (M) to a polymerization-prone monomeric intermediate (M*) that oligomerizes to form 
hyperstable polymers (P) (14, 17): 
 
M ↔ M* (+M*) → P 
 
The native and intermediate states are considerably less thermodynamically stable than the 
polymeric form, to the extent that the polymerization step is essentially irreversible; consequently, 
techniques that interrogate this pathway observe a partially kinetic rather than an equilibrium 
process.  Thermal denaturation experiments using SYPRO Orange involve an incremental increase 
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in temperature (typically 1°C min-1), and provide a measure of the stability of the native state of a 
protein, reported as the temperature at which a 50% “unfolding” is observed (Tm).  For α1-
antitrypsin, this reports the uni-molecular conversion from the native state to the polymerization 
intermediate (21). 
 
This assay showed a general lack of reversibility when temperature was decreased following a 
period of heating (Supp. Fig. E1D).  This reflected an inability of the system to achieve equilibrium, 
an effect that could be accounted for by varying the rate of temperature increase (36).  Accordingly, 
the three variants were heated at increments of 0.5, 0.9, 1.4, 2.4, 3.2 and 9.0°C min-1 (rates 
determined a posteriori by measurement within the instrument during the experiment). The 
resulting Tm values were indeed influenced by the temperature ramp, confirming that the results 
are influenced by kinetic, rather than equilibrium processes (Fig. 4A, left panel).  The apparent 
height of the energy barrier to intermediate formation, Eact,app was derived from the slopes of the 
regressions (Fig. 4A, right panel).  ATZ was found to have a lower kinetic barrier (by 160±45 kJ mol-
1) to intermediate formation than ATM, qualitatively consistent with results obtained for the rate of 
unfolding in denaturant (34), and for ATA336P this was lower still (by 280±40 kJ mol-1). Thus, ATA336P 
is able to convert to the intermediate from the native state (M→M*) more readily than ATZ or ATM. 
 
 
Ala336Pro increases the rate of polymerization  
 
FRET (Förster resonance energy transfer) can be used to monitor the heat-induced incorporation 
of α1-antitrypsin monomers into a growing polymer chain (17, 21, 22).  The half-time of 
fluorescence increase was determined at a range of temperatures between 50-60°C (Fig. 4B, left 
panel).   From a comparison of rates with ATM and ATZ on an Årrhenius plot (Fig. 4B, right panel), a 
downward shift was evident for ATA336P.  This reflects a considerably faster polymerization at all 
temperatures surveyed.  The regression line permitted interpolation of a half-time at the median 
temperature of 55°C, at which ATZ was found to polymerize 3.6 times and ATA336P 21 times more 
quickly than ATM (Fig. 4C, left panel). 
 
 
Ala336Pro has specific effects on the polymerization mechanism 
 
The slopes of the regression lines on the Årrhenius plot provide an indication of the energy barrier 
to oligomerization (M*+M*→ P) (17, 21).  The values were found to be comparable for ATM and 
ATZ, but that of ATA336P was considerably lower (Fig. 4C, right panel).  Thus, in contrast to ATZ, this 
mutation has effects on both phases of polymerization (M→M* and M*+ M*→P). 
We have previously reported a stability–polymerization profile that reflects the consensus 
relationship between the rate of polymerization and effects on native state stability (21).  
Deviations from this trend are diagnostic for specific effects of a mutation on the polymerization 
mechanism itself.  Under the conditions of these experiments, this was found to be the case for both 
ATZ and ATA336P with respect to ATM (Fig. 4D).   
 
 
Discussion 
 
Here we describe a novel mutant of α1-antitrypsin in a homozygous individual who is healthy and 
has no personal or family medical history suggestive of α1-antitrypsin deficiency. The 
comprehensive biophysical and biochemical characterization of the novel ATA336P variant allows 
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detailed comparison with the classic ATZ variant that is associated with severe lung and liver 
disease.  This can be correlated with clinical chemistry findings, to inform her ongoing management 
and investigation and provide genetic counseling regarding the implications for her children; they 
are obligate carriers of at least one copy of the novel allele.  The index individual has a profound 
functional deficiency of circulating ATA336P due to multiple factors; in addition to reduced 
circulating levels of total α1-antitrypsin in a range conventionally associated with moderate clinical 
significance, the protein is predominantly polymeric and the native monomer is far less effective as 
an antiprotease relative to the wild-type protein ATM.  The resultant loss-of-function is of similar 
severity to that observed in ATZ (PiZZ) homozygotes.  
 
Such 'experiments of nature' can also inform upon details of the mechanisms by which α1-
antitrypsin inhibits lung proteases in health and is subject to misfolding and polymerization in 
disease. The inhibitory mechanism involves translocation of a covalently bound protease by around 
70 Å to the opposite pole of the molecule as the RCL becomes incorporated as additional strand 
within β-sheet A (s4A) (37).  The Glu342Lys mutation in Z antitrypsin is situated in the ‘breach’ 
region of β-sheet A (Fig. 1A), which is the point of first incorporation for the RCL.  Whilst the loss of 
the associated salt bridge has minimal consequences for the thermodynamic stability of the 
molecule (34), it is known that the result is a less efficient protease inhibitor than the wild-type 
protein reflected by a reduction in activity of around 30% (38).  This suggests a defect in the 
mechanism of conformational change.  Additionally, a decrease in the rate of association is 
observed, indicative of a non-native RCL presentation (13).  The more pronounced perturbation of 
the inhibitory behavior by the Ala336Pro mutation – an SI of 2.7 and an SI-adjusted kass of 2.8×105 
M-1 s-1 - similarly reflects the effects on β-sheet A and the conformation of the RCL, respectively, 
despite a location for the mutation that is 6 amino acids N-terminal to that of the Z allele.  During 
the inhibitory process, helix F and the post-helix F loop represent a barrier that undergoes 
deformation in order to accommodate the translocating protease; these elements lie in the vicinity 
of Ala336 (39, 40).  The thermodynamic destabilization of the inserted state (Fig. 3B) due to ‘edge-
strand-effects’ (Fig. 1A, right panels) may reduce the energetic impetus that drives RCL insertion.  
This would provide an opportunity for the enzyme to become deacylated and escape the covalent 
complex.   
 
Characterizing the folding of α1-antitrypsin to a metastable native state, whether as a purified 
polypeptide or within cells, and misfolding in disease, are important research goals. Comparative 
refolding and equilibrium denaturant studies in ATM, ATZ and ATA336P further inform on specifics of 
the process.  Our observations suggest that Glu342 acts as a ‘gatekeeper’ residue, guiding the 
correct placement of the top of s5A in the folding intermediate, but that the nature of the residue at 
this position becomes far less important in thermodynamic stabilization of the native state.  The 
central portion of s5A in contrast plays a more pronounced role in the native state than the 
intermediate, consistent with experiments using hydrogen-deuterium exchange that show this 
region to be in a slow exchange regimen, reflecting low conformational lability in ATM (41).   
 
The combination of low circulating α1-antitrypsin levels and the observation that polymers of 
ATA336P were present in the plasma of the affected individual, indicated that the novel mutation was 
polymerogenic.  This was confirmed by characterization of the purified protein: reduced barriers to 
both intermediate formation and oligomerization were evident, rendering it more polymerization-
prone than either ATZ or ATM.  Whilst the thermodynamic stability of the native state of ATZ is 
comparable to ATM - with differences residing in the rate of interchange between native and 
unfolding intermediate – equilibrium denaturant and thermal unfolding showed the native and 
cleaved state of ATA336P to be less stable than either (Fig. 3B, Fig. 3A and Fig. 4A, left). However both 
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ATA336P and ATZ predispose to polymerization by additional effects beyond global destabilization of 
the fold. They therefore act by specifically promoting conformational changes required for 
polymerization. The finding that folding and polymerization are differentially affected by 
Ala336Pro and Glu342Lys mutations indicates that the overall degree of misfolding and 
polymerization are not directly related in α1-antitrypsin deficiency variants. 
 
Challenge of monomeric α1-antitrypsin by heat or denaturant results in polymers with different 
electrophoretic, immunological and structural characteristics (42, 43), but only the former share a 
conformational epitope with ex vivo pathological polymers (9, 42).  It is likely that this difference is 
also manifest in intermediate ensembles induced by the two approaches.  Indeed, the heat-induced 
α1-antitrypsin intermediate shows evidence for a more compact state than that observed in 1M 
guanidinium hydrochloride (41, 42, 44).  However, regional differences in s5A behavior are similar 
in both the denaturant-mediated and heat-induced polymerization (Table 2 and Fig. 4C, right). The 
Ala336Pro mutation influences stability of the denaturant-induced intermediate against further 
unfolding, and enhances the propensity of the thermal intermediate or refolded material to 
oligomerize.  In contrast, the Glu342Lys mutation does not influence these steps.   
 
The highly polymerogenic nature of the ATA336P mutation clearly renders the homozygous 
individual more vulnerable to lung disease through loss-of-function. With regard to the liver 
disease, our detailed characterization of this protein allows us to place it into a class of mutants that 
exhibit similar properties.  Specifically, its high propensity to polymerize, in common with 
neighboring shutter domain mutants associated with liver disease (45), indicates this individual 
should continue to be monitored for evidence of liver dysfunction. Thus insights from basic science, 
closely related to clinical context, are now guiding the personalized management of the ATA336P α1-
antitrypsin homozygote. 
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(H) Tables 
 
Table 1.  The effect of the Ala336Pro mutation on protease inhibition 
Stoichiometries of inhibition (SI) and association rate constants (kass) were determined against 
bovine α-chymotrypsin at 25°C.  Standard errors are calculated from three independent 
experiments. 
 
Variant SI* kass (M-1 s-1) kassS.I (M-1 s-1) Notional 
rate† 
ATM 1.0 2.65±0.13 x 105 2.65 x 105 100% 
ATZ 1.5 0.93±0.10 x 105 1.40 x 105 3.5% 
ATA336P 2.7 0.13±0.03 x 105 0.35 x 105 1.0% 
* Standard errors were less than 5%. 
† Calculated as the rate of inhibition (in s-1) relative to ATM at a typical concentration (2, 0.2 and 0.4 
mg/ml for ATM, ATZ, and ATA336P  respectively) if this were entirely circulating as native monomer. 
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Table 2. Equilibrium unfolding transition midpoints of α1-antitrypsin variants 
The midpoints of denaturation (in guanidium hydrochloride) were obtained by fitting a function 
describing three-state unfolding to the equilibrium denaturation profiles in Fig. 3A.  The standard 
errors of the fits are shown. 
 
 Midpoint (GdnHCl M) 
Variant N→I I→U 
ATM 0.94±0.03 2.43±0.03 
ATZ 1.33±0.09 2.43±0.06 
ATAla336Pro 0.42±0.04 2.27±0.03 
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 (J) Figure Legends 
 
Figure 1.  Characteristics of patient derived α1-antitrypsin.  (A) Left panels: Structure cartoon of 
the wild-type protein [accession 1QLP (18)] generated using PyMol (46) showing the position of 
Ala336 in the standard β-sheet A (“A-sheet”) view and rotated counterclockwise by 90°, with the 
reactive centre loop (“RCL”) indicated.  Sheets A, B and C are colored red, pink and yellow, 
respectively.  Right panels: An energy-minimized molecular model of ATA336P compared with the 
wild-type coordinates treated in the same manner using NAMD (20) and VMD (19).  The arrows 
indicate the loss of two main-chain hydrogen bonds (depicted as hatched lines) in the model 
between strands 5A and 6A. (B) Western blot analysis of patient derived plasma from MM, ZZ and 
Ala336Pro/Ala336Pro homozygotes separated by 3–12% w/v non-denaturing PAGE with detection 
by rabbit polyclonal (“Total”) and polymer-specific (“2C1”) antibodies.  Higher order bands 
represent polymeric species.  The ATA336P polymer is recognized by 2C1, demonstrating the 
presence of an epitope shared with the Z polymer. (C) Calculation of the SI of α1-antitrypsin 
variants against bovine α-chymotrypsin, showing residual activity at different ratios of inhibitor to 
enzyme.  Error bars denote standard deviations from three experiments.   
 
Figure 2.  Structural features of Ala336Pro.  (A) Assessment of overall secondary structure by 
far-UV circular dichroism (CD).  CD spectra of plasma-derived α1-antitrypsin, at 0.5 mg/ml in 10 
mM Na2HPO4/NaH2PO4 pH7.4, recorded between 250-190 nm, show similar profiles for the three 
variants.  (B) Assessment of breach opening (30) by intrinsic tryptophan fluorescence.  Spectra 
were recorded of 0.5 μM α1-antitrypsin in PBS with 5% v/v glycerol between 300-400 nm with 
excitation at 295 nm.  Ala336Pro shows increased fluorescence intensity and red shift in 
wavelength compared to ATM, however, to a lesser extent than ATZ α1-antitrypsin.  (C) 2 μM α1-
antitrypsin in PBS with 5% v/v glycerol was incubated with 10  μM bis-ANS for 10 minutes and the 
spectra recorded between 400-600 nm with excitation at 370 nm.  The increase in fluorescence was 
comparable to ATZ, suggesting increased population of the polymerization intermediate (34). 
 
Figure 3.  Equilibrium unfolding and rapid refolding of α1-antitrypsin. (A) Changes in intrinsic 
fluorescence centre of spectral mass (COSM) during equilibrium unfolding of 0.5 μM α1-antitrypsin 
are shown.  Values calculated at 6 M guanidinium hydrochloride were similar to those at 4 M.  
Samples were in 10 mM Na2HPO4/NaH2PO4, pH7.4. (B) ATM, ATZ and ATA336P were cleaved 
overnight at a 50-fold molar excess with respect to Staphylococcus aureus protease V8, and 
incubated for 2 hours in increasing concentrations of guanidinium hydrochloride before separation 
by 6 M urea PAGE.  In each 8% acrylamide gel, native and cleaved protein in the absence of 
denaturant (left two lanes) were used as controls.  Unfolding of the protein resulted in a decreased 
rate of migration.  This shift in behavior occurred at a lower concentration for ATA336P than the 
other variants. (C) Top: 1 μg of α1-antitrypsin was concentrated to 10mg/ml in PBS with 5% v/v 
glycerol, C, or in 6 M guanidinium hydrochloride, R, before 200 fold dilution into PBS with 5% v/v 
glycerol.  Samples were resolved on a 3–12% w/v non-denaturing gel stained with Coomassie 
Brilliant Blue.  M, I and P represent the positions of monomer, intermediate and polymer fractions 
respectively (42).  Bottom:  Analysis of refolding by densitometry.  Each bar represents the total 
protein regained on refolding compared to the control, C, samples.  Demarcation of the bars 
represents the proportion of conformer regained.  
 
Figure 4.  The effects of Ala336Pro on thermal stability. (A) Left: Conversion of ATM, ATZ and 
ATA336P variants from native to intermediate upon heating between 25°C and 95°C was monitored 
in PBS using SYPRO Orange dye (21), and the midpoint of the thermal transition, Tm, plotted as a 
For Review Only
 20
function of rate of temperature increase (47). Right: the calculated apparent activation energy 
values, Eact,app, for the transition between native and intermediate states, calculated from the slopes 
of the regressions. (B) Left: ATA336P, labeled with Alexa 488 and Alexa 594 dyes at Cys232 in 
equimolar ratios, was heated over a range of temperatures at 0.1 mg/ml in PBS and the increase in 
FRET monitored.  Typical results of an experiment are shown (solid black lines), with curves of best 
fit (dashed grey lines).  Right: Half-times of polymerization of ATA336P were determined from FRET 
progress curves at a range of temperatures and subjected to an Årrhenius analysis (17, 21).  (C) 
Left: the Årrhenius plot was used to interpolate a polymerization half-time for the variants at a 
single reference temperature (55°C).  The polymerization of ATA336P was faster than for either ATZ 
or ATM variants.  Right: the apparent activation energy for polymerization, Eact,app, was calculated 
from the Årrhenius plot.  This was significantly lower for ATA336P than either the ATM or ATZ 
variants, as judged by a one-way ANOVA (p<0.05). (D) Half-times of polymerization at 55°C and the 
Tm values of the ATZ and ATA336P variants are shown relative to that of ATM.  The dashed lines 
represent a consensus relationship between a rate of polymerization dictated by native state 
stability (21). 
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Figure 1.  Characteristics of patient derived α1-antitrypsin.  (A) Left panels: Structure cartoon of the 
wild-type protein [accession 1QLP (18)] generated using PyMol (46) showing the position of Ala336 in the 
standard β-sheet A (“A-sheet”) view and rotated counterclockwise by 90°, with the reactive centre loop 
(“RCL”) indicated.  Sheets A, B and C are colored red, pink and yellow, respectively.  Right panels: An 
energy-minimized molecular model of ATA336P compared with the wild-type coordinates treated in the same 
manner using NAMD (20) and VMD (19).  The arrows indicate the loss of two main-chain hydrogen bonds 
(depicted as hatched lines) in the model between strands 5A and 6A. (B) Western blot analysis of patient 
derived plasma from MM, ZZ and Ala336Pro/Ala336Pro homozygotes separated by 3–12% w/v non-
denaturing PAGE with detection by rabbit polyclonal (“Total”) and polymer-specific (“2C1”) 
antibodies.  Higher order bands represent polymeric species.  The ATA336P polymer is recognized by 2C1, 
demonstrating the presence of an epitope shared with the Z polymer. (C) Calculation of the SI of α1-
antitrypsin variants against bovine α-chymotrypsin, showing residual activity at different ratios of inhibitor to 
enzyme.  Error bars denote standard deviations from three experiments.  
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Figure 2.  Structural features of Ala336Pro.  (A) Assessment of overall secondary structure by far-UV 
circular dichroism (CD).  CD spectra of plasma-derived α1-antitrypsin, at 0.5 mg/ml in 10 mM 
Na2HPO4/NaH2PO4 pH7.4, recorded between 250-190 nm, show similar profiles for the three variants.  (B) 
Assessment of breach opening (30) by intrinsic tryptophan fluorescence.  Spectra were recorded of 0.5 µM 
α1-antitrypsin in PBS with 5% v/v glycerol between 300-400 nm with excitation at 295 nm.  Ala336Pro 
shows increased fluorescence intensity and red shift in wavelength compared to ATM, however, to a lesser 
extent than ATZ α1-antitrypsin.  (C) 2 µM α1-antitrypsin in PBS with 5% v/v glycerol was incubated with 
10  µM bis-ANS for 10 minutes and the spectra recorded between 400-600 nm with excitation at 370 
nm.  The increase in fluorescence was comparable to ATZ, suggesting increased population of the 
polymerization intermediate (34).  
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Figure 3.  Equilibrium unfolding and rapid refolding of α1-antitrypsin. (A) Changes in intrinsic 
fluorescence centre of spectral mass (COSM) during equilibrium unfolding of 0.5 µM α1-antitrypsin are 
shown.  Values calculated at 6 M guanidinium hydrochloride were similar to those at 4 M.  Samples were in 
10 mM Na2HPO4/NaH2PO4, pH7.4. (B) ATM, ATZ and ATA336P were cleaved overnight at a 50-fold molar excess 
with respect to Staphylococcus aureus protease V8, and incubated for 2 hours in increasing concentrations 
of guanidinium hydrochloride before separation by 6 M urea PAGE.  In each 8% acrylamide gel, native and 
cleaved protein in the absence of denaturant (left two lanes) were used as controls.  Unfolding of the protein 
resulted in a decreased rate of migration.  This shift in behavior occurred at a lower concentration for ATA336P 
than the other variants. (C) Top: 1 µg of α1-antitrypsin was concentrated to 10mg/ml in PBS with 5% v/v 
glycerol, C, or in 6 M guanidinium hydrochloride, R, before 200 fold dilution into PBS with 5% v/v 
glycerol.  Samples were resolved on a 3–12% w/v non-denaturing gel stained with Coomassie Brilliant 
Blue.  M, I and P represent the positions of monomer, intermediate and polymer fractions respectively (42). 
Bottom:  Analysis of refolding by densitometry.  Each bar represents the total protein regained on refolding 
compared to the control, C, samples.  Demarcation of the bars represents the proportion of conformer 
regained.  
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Figure 4.  The effects of Ala336Pro on thermal stability. (A) Left: Conversion of ATM, ATZ and ATA336P 
variants from native to intermediate upon heating between 25°C and 95°C was monitored in PBS using 
SYPRO Orange dye (21), and the midpoint of the thermal transition, Tm, plotted as a function of rate of 
temperature increase (47). Right: the calculated apparent activation energy values, Eact,app, for the transition 
between native and intermediate states, calculated from the slopes of the regressions. (B) Left: ATA336P, 
labeled with Alexa 488 and Alexa 594 dyes at Cys232 in equimolar ratios, was heated over a range of 
temperatures at 0.1 mg/ml in PBS and the increase in FRET monitored.  Typical results of an experiment are 
shown (solid black lines), with curves of best fit (dashed grey lines).  Right: Half-times of polymerization of 
ATA336P were determined from FRET progress curves at a range of temperatures and subjected to an 
Årrhenius analysis (17, 21).  (C) Left: the Årrhenius plot was used to interpolate a polymerization half-time 
for the variants at a single reference temperature (55°C).  The polymerization of ATA336P was faster than for 
either ATZ or ATM variants.  Right: the apparent activation energy for polymerization, Eact,app, was calculated 
from the Årrhenius plot.  This was significantly lower for ATA336P than either the ATM or ATZ variants, as 
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judged by a one-way ANOVA (p<0.05). (D) Half-times of polymerization at 55°C and the Tm values of the 
ATZ and ATA336P variants are shown relative to that of ATM.  The dashed lines represent a consensus 
relationship between a rate of polymerization dictated by native state stability (21).  
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Supplemental material 
 
Materials and Methods 
 
Molecular modeling of the A336P mutation   
 
The crystal structure of α1-antitrypsin [PDB accession 1QLP (E1)] was the basis for molecular 
dynamics simulations, with VMD (E2) and NAMD (E3) used for preparation/visualization and 
minimization/molecular dynamics, respectively.  The system was prepared for production 
molecular dynamics in the following way: (a) the alanine-to-proline mutation at position 336 was 
introduced; (b) hydrogens were added, the structure was placed in a water box with 1 nm borders, 
and the overall charge neutralized using sodium ions; (c) the solvent and protein hydrogens were 
minimized with the protein non-hydrogen atoms fixed for 10k cycles; (d) the protein was 
minimized with the solvent fixed for 10k cycles; and (e) both were minimized together for 10k 
cycles.  A 5 ns production molecular dynamics run at 37°C was performed, with snapshots taken at 
0.5 ps intervals.  The resulting model was obtained as follows: (a) the root-mean-square deviation 
of Cα atoms was calculated relative to the starting structure; (b) the snapshots were averaged 
across the stable portion of the molecular dynamics trajectory, starting at round 0.4 ns; and (c) a 
final found of energy minimization of 2.5k cycles was performed.  This process was also performed 
for the wild-type protein. 
 
Supplementary Figure E1.  (A) Portion of the isoelectric focusing gel that yielded an inconclusive 
result for the Ala336Pro/Ala336Pro homozygote (“sample”).  The positions of bands corresponding 
to Z and S alleles are indicated. (B) ‘Cut-through’ figure showing the atomic packing of Ala336 
(colored red) relative to the sites of other shutter domain mutations, shaded grey. (C) 2μg of each 
α1-antitrypsin variant was incubated with bovine α-chymotrypsin at a 1:1 molar ratio to active 
monomer in chymotrypsin assay buffer for 15 min at room temperature. Samples were mixed with 
SDS loading buffer without boiling and separated by 4-12% w/v SDS-PAGE, and visualized by 
Coomassie Brilliant Blue.  The gel shows the ability of all variants to form SDS-stable serpin-enzyme 
complex. P indicates protease alone, A indicates α1-antitrypsin alone and C indicates protease 
incubated with α1-antitrypsin; the positions of covalent complex (with and without secondary 
cleavage), intact and non-productively cleaved α1-antitrypsin and  α-chymotrypsin are also 
indicated. (D) Molecular dynamics simulation with wild-type (“A336A”) and mutant (“A336P”) 
models was performed at 37°C with sampling at 0.5 ps intervals.  RMSDref denotes the root-mean-
square deviation of Cα atoms with respect to the starting models, and show stabilization of the 
trajectory at around 0.4 ns.  (E) Cartoon representation of the molecular model of ATA336P, 
highlighting the predicted disruption of strand 6A by the Ala336Pro mutation. (F) ATM at 0.1 mg/ml 
in PBS was heated from 25°C to 55°C and cooled back to 25°C at a rate of 5°C min-1, with 
conformational change monitored using SYPRO Orange.  The profile shows a lack of reversibility of 
the transition upon cooling. 
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Supplementary Figure E1.  (A) Portion of the isoelectric focusing gel that yielded an inconclusive result for 
the Ala336Pro/Ala336Pro homozygote (“sample”).  The positions of bands corresponding to Z and S alleles 
are indicated. (B) ‘Cut-through’ figure showing the atomic packing of Ala336 (colored red) relative to the 
sites of other shutter domain mutations, shaded grey. (C) 2µg of each α1-antitrypsin variant was incubated 
with bovine α-chymotrypsin at a 1:1 molar ratio to active monomer in chymotrypsin assay buffer for 15 min 
at room temperature. Samples were mixed with SDS loading buffer without boiling and separated by 4-12% 
w/v SDS-PAGE, and visualized by Coomassie Brilliant Blue.  The gel shows the ability of all variants to form 
SDS-stable serpin-enzyme complex. P indicates protease alone, A indicates α1-antitrypsin alone and C 
indicates protease incubated with α1-antitrypsin; the positions of covalent complex (with and without 
secondary cleavage), intact and non-productively cleaved α1-antitrypsin and  α-chymotrypsin are also 
indicated. (D) Molecular dynamics simulation with wild-type (“A336A”) and mutant (“A336P”) models was 
performed at 37°C with sampling at 0.5 ps intervals.  RMSDref denotes the root-mean-square deviation of Cα 
atoms with respect to the starting models, and show stabilization of the trajectory at around 0.4 ns.  (E) 
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